VL21CEMAR1/SES104 - Containment - Understanding Why, When, and What Regulatory Agencies Expect

Description

Containment - Understanding Why, When, and What Regulatory Agencies Expect | For10 years - the Risk Based Manufacture of Pharmaceutical Products has defined expectations for cross contamination control to protect patients. Understand what cross contamination control: why it is needed, when it is needed, how to determine the extent of what is needed, and what the regulatory environment is regarding cross contamination control to protect patients. This protection translates into requirements to also protect operators.

Session Leader(s):

• Christa B. Myers, Senior Associate, Aseptic & Sterile Market Director, CRB

Speaker(s):

• Tom Evans, Director; Environmental Health and Safety, Abzena
• Christoph Knoop, PhD., Principal Research Scientist, AbbVie Deutschland GmbH & Co. KG
• Matthias Angelmaier, Global Product Manager, Isolator Technology, Syntegon Technology GmbH